Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143540 |
| CAS No | NA |
| Mol.F. | C7H9N3O4 |
| Mol.Wt. | 199.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143541 |
| CAS No | NA |
| Mol.F. | C7H8ClN3O3 |
| Mol.Wt. | 217.61g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143542 |
| CAS No | NA |
| Mol.F. | C15H24N4O3 |
| Mol.Wt. | 308.38 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143543 |
| CAS No | NA |
| Mol.F. | C28H37N5O8 |
| Mol.Wt. | 571.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143544 |
| CAS No | NA |
| Mol.F. | C28H37N5O8 |
| Mol.Wt. | 571.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143545 |
| CAS No | NA |
| Mol.F. | C28H36N6O9 |
| Mol.Wt. | 600.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143546 |
| CAS No | NA |
| Mol.F. | C29H39N5O8 |
| Mol.Wt. | 585.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143547 |
| CAS No | NA |
| Mol.F. | C29H41N5O8 |
| Mol.Wt. | 587.67g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143548 |
| CAS No | NA |
| Mol.F. | C26H32N4O8 |
| Mol.Wt. | 528.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143549 |
| CAS No | NA |
| Mol.F. | C27H32N4O9 |
| Mol.Wt. | 556.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143550 |
| CAS No | NA |
| Mol.F. | C30H41N5O9 |
| Mol.Wt. | 615.68 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143551 |
| CAS No | NA |
| Mol.F. | C29H37N5O8 |
| Mol.Wt. | 583.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143552 |
| CAS No | NA |
| Mol.F. | C28H38N4O7 |
| Mol.Wt. | 542.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143553 |
| CAS No | NA |
| Mol.F. | C29H40N6O7 |
| Mol.Wt. | 584.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143554 |
| CAS No | NA |
| Mol.F. | C29H39N5O8 |
| Mol.Wt. | 585.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143555 |
| CAS No | NA |
| Mol.F. | C25H32N6O8 |
| Mol.Wt. | 544.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |